Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) Share-based Compensation (IS) (2016 - 2022)

Medicure has reported Share-based Compensation (IS) over the past 8 years, most recently at -$2210.1 for Q4 2022.

  • For Q4 2022, Share-based Compensation (IS) rose 94.54% year-over-year to -$2210.1; the TTM value through Dec 2022 reached $36988.6, down 65.74%, while the annual FY2024 figure was $140306.4, 34.27% down from the prior year.
  • Share-based Compensation (IS) for Q4 2022 was -$2210.1 at Medicure, down from $4600.5 in the prior quarter.
  • Over five years, Share-based Compensation (IS) peaked at $329932.1 in Q1 2018 and troughed at -$40460.1 in Q4 2021.
  • A 5-year average of $74477.4 and a median of $58632.1 in 2020 define the central range for Share-based Compensation (IS).
  • Biggest five-year swings in Share-based Compensation (IS): skyrocketed 617.55% in 2018 and later tumbled 167.62% in 2021.
  • Year by year, Share-based Compensation (IS) stood at $153039.2 in 2018, then tumbled by 32.19% to $103777.3 in 2019, then crashed by 42.35% to $59830.3 in 2020, then tumbled by 167.62% to -$40460.1 in 2021, then soared by 94.54% to -$2210.1 in 2022.
  • Business Quant data shows Share-based Compensation (IS) for MCUJF at -$2210.1 in Q4 2022, $4600.5 in Q3 2022, and $21177.2 in Q2 2022.